943687.fig.004a
(a)
943687.fig.004b
(b)
943687.fig.004c
(c)
943687.fig.004d
(d)
943687.fig.004e
(e)
943687.fig.004f
(f)
943687.fig.004g
(g)
Figure 4: Histological presentation after H/E staining of liver of the mice treated with a single dose of subcutaneous wild type rhIFN-α2b or rhIFN-α2bC2DC99D (magnification 400x). (a) Control; (b) wild type rhIFN-α2b (D1); (c) rhIFN-α2bC2DC99D (D1); (d) wild type rhIFN-α2b (D2); (e) rhIFN-α2bC2DC99D (D2); (f) wild type rhIFN-α2b (D3); (g) rhIFN-α2bC2DC99D (D3).